Literature DB >> 15038051

Iron-containing nucleoside analogues with pronounced apoptosis-inducing activity.

Daniel Schlawe1, André Majdalani, Juraj Velcicky, Erik Hessler, Thomas Wieder, Aram Prokop, Hans-Günther Schmalz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15038051     DOI： 10.1002/anie.200353132

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  13 in total

1.  Similar biological activities of two isostructural ruthenium and osmium complexes.

Authors:  Jasna Maksimoska; Douglas S Williams; G Ekin Atilla-Gokcumen; Keiran S M Smalley; Patrick J Carroll; Richard D Webster; Panagis Filippakopoulos; Stefan Knapp; Meenhard Herlyn; Eric Meggers
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

2.  Recent Applications of Acyclic (Diene)iron Complexes and (Dienyl)iron Cations in Organic Synthesis.

Authors:  William A Donaldson; Subhabrata Chaudhury
Journal:  European J Org Chem       Date:  2009-08

3.  Iron containing anti-tumoral agents: unexpected apoptosis-inducing activity of a ferrocene amino acid derivative.

Authors:  Benjamin Kater; Andrea Hunold; Hans-G Schmalz; Lisa Kater; Birgit Bonitzki; Patrick Jesse; Aram Prokop
Journal:  J Cancer Res Clin Oncol       Date:  2010-06-11       Impact factor: 4.553

Review 4.  Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple strategies.

Authors:  Mehvash Zaki; Suboot Hairat; Elham S Aazam
Journal:  RSC Adv       Date:  2019-01-24       Impact factor: 4.036

5.  Synthesis and cyclometalation of a pyrido[3,2-e]-2,10b-diaza-cyclopenta[c]fluorene-1,3-dione scaffold.

Authors:  Seann P Mulcahy; Patrick J Carroll; Eric Meggers
Journal:  Tetrahedron Lett       Date:  2006-12-11       Impact factor: 2.415

Review 6.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

Review 7.  Organometallic anticancer compounds.

Authors:  Gilles Gasser; Ingo Ott; Nils Metzler-Nolte
Journal:  J Med Chem       Date:  2010-11-15       Impact factor: 7.446

8.  Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden.

Authors:  Christian Prinz; Elena Vasyutina; Gregor Lohmann; Alexandra Schrader; Steffen Romanski; Christoph Hirschhäuser; Petra Mayer; Corazon Frias; Carmen D Herling; Michael Hallek; Hans-Günther Schmalz; Aram Prokop; Dimitrios Mougiakakos; Marco Herling
Journal:  Mol Cancer       Date:  2015-06-04       Impact factor: 27.401

Review 9.  Aspects of Carbon Monoxide in Form of CO-Releasing Molecules Used in Cancer Treatment: More Light on the Way.

Authors:  Malamati Kourti; Wen G Jiang; Jun Cai
Journal:  Oxid Med Cell Longev       Date:  2017-02-13       Impact factor: 6.543

Review 10.  New trends for metal complexes with anticancer activity.

Authors:  Pieter C A Bruijnincx; Peter J Sadler
Journal:  Curr Opin Chem Biol       Date:  2008-01-25       Impact factor: 8.822
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.